Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer’s Disease: A Retrospective Inception Cohort Study

BACKGROUND: Animal studies suggested that β2-Adrenergic receptors (β2AR) may be a potential target for the treatment of Alzheimer’s disease (AD). OBJECTIVE: This retrospective inception cohort study aimed to assess the association between antagonists and agonists of the β2AR and the risk of starting...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutten, Danique R., Bos, Jens H.J., de Vos, Stijn, Hak, Eelko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198755/
https://www.ncbi.nlm.nih.gov/pubmed/35466934
http://dx.doi.org/10.3233/JAD-215057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198755/
https://www.ncbi.nlm.nih.gov/pubmed/35466934
http://dx.doi.org/10.3233/JAD-215057

Ejemplares similares